Organon & Co. (OGN): EPS (Basic)
$0.72
Year ended 2025-12-31
-41.6%
3-year compound annual growth
-39.0%
5-year compound annual growth
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0.72 | -78.6% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $3.36 | -16.2% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $4.01 | +11.1% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $3.61 | -32.3% | 2025-11-10, From 2022-01-01 |
| 2021-12-31 | $5.33 | -37.4% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $8.52 | -32.9% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $12.69 | n/a | 2022-03-21, From 2019-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Organon & Co. (OGN) | 2025-12-31 | $0.72 | -78.6% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $0.20 | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | -$0.47 | n/m |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$5.84 | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$10.29 | n/m |
| Zoetis Inc. (ZTS) | 2025-12-31 | $6.03 | +10.2% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $0.42 | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $2.39 | n/m |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $1.82 | -19.1% |
Compare OGN, ONC, ELAN, JAZZ side by side · Screen every company in Pharmaceutical Preparations ↗